Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 6, 2003, Pages 503-506

  Choi, Sung W ^a,d   Bangaru, Babu S ^a   Wu, C Daniel ^a,c   Finlay, Jonathan L ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Division of Pediatric Oncology   (United States)

^c IMPATH Inc   (United States)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

2 Chlorodeoxyadenosine; Cytarabine; Gastrointestinal involvement; Langerhans cell histiocytosis

Indexed keywords

CLADRIBINE; CYTARABINE; METHYLPREDNISOLONE; PREDNISONE; VINBLASTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL DISEASE; HISTIOCYTOSIS X; HUMAN; INFANT; MALE; PRIORITY JOURNAL; PROGNOSIS; SKIN BIOPSY; TREATMENT OUTCOME;

BIOPSY; CLADRIBINE; CYTARABINE; DRUG THERAPY, COMBINATION; GASTROINTESTINAL DISEASES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE;

EID: 0037601831     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200306000-00016     Document Type: Article

References (17)

1. Lahey ME. Prognostic factors in histiocytosis X. Am J Pediatr Hematol Oncol 1981;3:57-60.
2. Rivera-Luna R, Alter-Molchadsky N, Cardenas-Cardos R, et al. Langerhans cell histiocytosis in children under 2 years of age. Med Pediatr Oncol 1996;26:334-343.
3. Lee RG, Braziel RM, Stenzel P. Gastrointestinal involvement in Langerhans cell histocytosis (histiocytosis X): diagnosis by rectal biopsy. Mod Pathol 1990;3: 154-157.
4. Egeler RM, Schipper MEI, Heymans HAS. Gastrointestinal involvement in Langerhans' cell histiocytosis (Histiocytosis X): a clinical report of three cases. Eur J Pediatr 1990;149:325-329.
5. Boccon-Gibod LA, Krichen HA, Carlier-Mercier LMB, et al. Digestive tract involvement with exudative enteropathy in langerhans cell histiocytosis. Pediatr Pathol 1992;12:515-524.
6. The French Langerhans' Cell Histiocytosis Study Group. A multicenter retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75:17-24.
7. Gadner H, Heitger A, Grois N, Gatterer-Menz I, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatri Oncol 1994;23:72-80.
8. Santos-Machado TM, Cristofani LM, Almeida MTA, et al. Disseminated Langerhans' cell histiocytosis and massive protein-losing enteropathy. Braz J Med Bio Res 1999;32:1095-1099.
9. Tamura T, Umetsu M, Motoya H, et al. Congenital Letterer-Siwe disease associated with protein losing enteropathy. Eur J Pediatr 1980;135:77-80.
10. Nanduri VR, Kelly K, Malone M, et al. Colon involvement in Langerhans' cell histiocytosis. J Pediatr Gastroenterol Nutr 1999;29:462-466.
11. Levy J, Khaskelberg A, Garvin J. Langerhans cell histiocytosis (LCH) involving the gastrointestinal tract: a clinical-electrogastrographic correlation. J Pediatr Gastoenterol Nutr 2001;33:511-514.
12. Patel BJ, Chippindale AJ, Gupta SC. Case report: small bowel histiocytosis-X. Clin Radiol 1991;44:62-63.
13. Geissman F, Thomas C, Emile JF, et al. Digestive tract involvement in Langerhans cell histiocytosis. J Pediatr 1996;129:836-845.
14. Stine KC, Saylors RL, Williams LL, et al. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol 1997;29:288-292.
15. Carrera CJ, Terai C, Lotz M, et al. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. J Clin Invest 1990;86:1480-1488.
16. Weitzman S, Wayne AS, Arceci R, Lipton JM, et al. Nucleoside analogues in the therapy of langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature. Med Pediatr Oncol 1999;33: 476-491.
17. Gandhi V, Estey E, Keating MJ, et al. Chlorodeoxyadenosine and arabinosyl-cytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions. Blood 1996;87:256-264.